Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Dextromethorphan to Treat Patients With Voice Spasms [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating dextromethorphan for voice disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextromethorphan (dextromethorphan)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Voice Disorders | Phase 1 | Status: COMPLETED